Services Overview

We act as your agent, representative, interim or mentor/coach. We can set up your company in Japan. We are dedicated to making your commercial success real!

We supply the market intelligence you need to be successful in Japan!

We connect you with the right Japanese companies within Biopharma, ATMP, CGT, Regenerative Medicine, Pharmaceuticals, Combination Devices, IVD’s, Universities and distributors. The right mix you need among: Trade Shows, KOLs, customers, partners, distributors . . .

A handshake under the Rising Sun of Japan.

Biosector = Commercialization in Japan

Preparation and reports – What you need to know!

We produce your feasibility studies and all other types of reports that you need to unlock your commercial pathway into Japan’s Pharmaceutical Industry. We help pave every step of your commercialization process.

Download for free:

You need: fast, accurate and actionable reports, feasibility studies, target lists and analysis to be able to draw up the best strategies.

We supply: just that!

By partnering with Biosector, you get the upper hand!

Market Entry: Seamless Integration and Strategic Positioning

Your success in Japan requires the following keys:

  1. Budget
  2. Cultural competence
  3. Clear goals
  4. Strategic approach
  5. Feet on the ground
  6. Long term mindset
  7. Patience
  8. Consistency


We make sure you are moving as fast as possible and that your expectations are aligned with those of your future clients and partners’ in Japan.

Market Expansion: Optimizing Your New Commercial Opportunities and Accelerating Growth

Expanding your footprint in Japan is crucial. Accelerating your growth successfully equals long-term success. You need competence and excellence: we supply! You need to optimize your new avenues for growth – we support you! We assist you in making sure of your new market segments and their strategies.

Leveraging your opportunities through our extensive industry connections is a valuable shortcut.

With Biosector, you have the advantage that only comes with exceptional professionals. Every step of the way.

About Stefan Sandström 

CEO of Biosector Ltd. Residence

Residence: Based in Metropolitan Tokyo since 2007.

Unique Perspective: Science and business.

Education: Medicine and chemical engineering.

Leadership: Successfully led multiple industrial companies as CEO.

Accreditations: Accredited business consultant via  German RKW.

Collaborations: Japanese partner to notable entities:  SPECTARIS and Kalms Consulting.

Recognitions: Appointed as an expert on conducting business in Japan by the EU-Japan Centre for Industrial Cooperation.

Track Record: Three decades of experience in international and cross-border business development, achieving first sales.

Passion: Kendo (martial art) with the rank of 6 dan.

Testimonials/Cases

Dan Spacie

CEO of MAP Patient Access, UK

”I have worked with Stefan Sandström outside of Biosector for over a year and will continue to work with him in Biosector. This is an exceptionally highly skilled partner, walking the extra mile and having made all the difference for building our traction in Japan.”

Anne-Kathrin Schmalz

Senior Manager Foreign Trade and Export Promotion

”Mr Sandström delivered an amazing seminar for our members in Sep 2021. He combined extensive specialist knowledge of the Japanese bio and laboratory market and how to bridge cultural differences. ”

Tony White

“Biosector’s business intelligence has helped me identify investment opportunities I would never have discovered. They deliver incisive analysis applying the Pareto Principle, allowing me to make fast decisions and save huge amounts of time. A great help for guiding the next steps forward.” – Tony White, founder of BioPhorum and angel investor

Blog

Abstract illustration representing Japan’s SaMD commercialization ecosystem.
Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools as part of its national care infrastructure. SaMD was once treated cautiously, however, the industry now benefits from clearer regulatory pathways, pilot reimbursement mechanisms, and a growing appetite for tech-enabled […]
Timeline collage of vintage lab tools, 1990s computer, and glowing AI brain in a modern Japanese lab.
From Automation to Inflexion: AI’s Historical Trajectory in Pharma The pharmaceutical industry began its journey with structured automation. Early systems focused on lab scheduling, batch record control, and analytical data management. These efforts enhanced operational consistency. However, they offered limited cognitive capabilities. AI, in its modern […]
Speaker presenting at the launch event of TOBU on-demand biobank in Japan.
Some of Japan’s most forward-thinking minds gathered to scrutinise Japan’s biobank conundrum at Shonan iPark. In the lectures and talks the speakers traded polite optimism for Japan’s pending success for operational urgency. The speakers stringently identified the gaps between research and industrial application. They proposed blueprints […]
Navigating Japan’s life sciences sector successfully hinges on more than just excellent science or a meticulously translated pitch; it demands a deep understanding of its intricate business culture and robust local networks. This is where our expertise in bridging cultural divides truly shines. Biosector doesn’t just […]
It started with a headline I read on the train to kendo practice. AstraZeneca is setting wildly ambitious approval targets in Japan. That led me to write a prompt including J&J’s equally ultra-ambitious goals in Japan with Gemini Advanced 2.1 Deep Research. That prompt gave me […]
Illustration of Japan’s evolving drug pricing trends with a balance scale metaphor.
Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for pharma, with relentless price cuts eroding profitability and leading the way to last year’s scandals as companies couldn’t afford to follow the strict protcols. But this year, things have changed! […]

Please feel warmly welcome to contact us:

email: info@biosector.jp
phone: +81 80-3404-8431

Address: Yokohama Landmark Tower, 20th Floor, 2-2-1 Minatomirai, Nishi-ku, 〒220-8120,

Yokohama, JAPAN

Deliveries: Kosugaya 1-20-6-202, Sakae-ku, 〒247-0007, Yokohama, JAPAN